Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656
Enrollment(s)
26
Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction
Dual Antiplatelet Therapy
COMPLETED
NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
1
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Autosomal Dominant Polycystic Kidney Disease
RECRUITING
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
60
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Acute Myeloid Leukemia in Children
COMPLETED
NCT06772246
A Study to Evaluate QTc Prolongation With Quizartinib in Healthy Subjects Under Rapid Acceleration of Heart Rate
70
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Healthy Subjects
RECRUITING
NCT07073755
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
200
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer
Drug Resistance
Hormone Receptor-Positive Breast Cancer
HER2-positive Breast Cancer
Triple-Negative Breast Cancer (TNBC)
Treatment Decisions
RECRUITING
NCT07065435
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
74
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
HER2 + Breast Cancer
ACTIVE_NOT_RECRUITING
NCT05650879
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
198
Enrollment(s)
39
Study location(s)
INTERVENTIONAL (PHASE1)
HER2 Mutant Non-small Cell Lung Cancer
HER2-positive Metastatic Breast Cancer
HER2 Gene Mutation
HER2 Amplification
ACTIVE_NOT_RECRUITING
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
1,200
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Acute Ischemic Stroke
Atrial Fibrillation
Extracranial Atherosclerosis
Intracranial Atherosclerosis
Coronary Artery Atherosclerosis
Peripheral Artery Stenosis
Anticoagulant
Antiplatelet
21
22
23
24
25